Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-3-30
pubmed:abstractText
Elevated glucose level on admission is common in patients with acute coronary syndrome (ACS) and has been shown to be a strong predictor of adverse outcome in patients both with and without diabetes. The purpose of the study was to assess the impact of admission glucose on in-hospital mortality in patients with non-ST-segment elevation ACS treated in hospitals without on-site invasive facilities. We identified 807 patients with non-ST-segment elevation ACS treated conservatively in the 29 hospitals participating in the Krakow Registry of Acute Coronary Syndromes; 763 patients with complete admission glucose data were stratified according to admission glucose level. Of these, 24.2% had admission glucose level <5, 50.6% had a level 5 to 6.9, 10.9% had a level 7 to 8.9, 6.7% had a level 9 to 10.9, and 7.6% had a level > or =11 mmol/L. In-hospital mortality was higher in patients with higher admission glucose (admission glucose <5, 5 to 6.9, 7 to 8.9, 9 to 10.9, and > or =11 mmol/L: 0.5%, 2.6%, 7.2%, 9.8%, and 24.1% respectively, p <0.0001). Similarly, significant mortality difference was observed in patient subgroups stratified by admission glucose level and presence of diabetes mellitus and cardiogenic shock. Independent predictors of in-hospital death were age, cardiogenic shock, admission glucose, chronic obstructive pulmonary disease, and renal insufficiency. In conclusion, admission glucose level is a strong predictor of in-hospital death in patients with non-ST-segment elevation ACS remaining in hospitals without on-site invasive facilities. Impact of admission glucose on mortality is independent of diabetes and cardiogenic shock presence.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1879-1913
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
954-8
pubmed:meshHeading
pubmed-meshheading:19327422-Acute Coronary Syndrome, pubmed-meshheading:19327422-Aged, pubmed-meshheading:19327422-Blood Glucose, pubmed-meshheading:19327422-Diabetes Mellitus, pubmed-meshheading:19327422-Diagnostic Tests, Routine, pubmed-meshheading:19327422-Electrocardiography, pubmed-meshheading:19327422-Female, pubmed-meshheading:19327422-Follow-Up Studies, pubmed-meshheading:19327422-Hospital Mortality, pubmed-meshheading:19327422-Humans, pubmed-meshheading:19327422-Male, pubmed-meshheading:19327422-Middle Aged, pubmed-meshheading:19327422-Patient Admission, pubmed-meshheading:19327422-Poland, pubmed-meshheading:19327422-Prognosis, pubmed-meshheading:19327422-Prospective Studies, pubmed-meshheading:19327422-Reproducibility of Results, pubmed-meshheading:19327422-Survival Rate, pubmed-meshheading:19327422-Vasodilator Agents
pubmed:year
2009
pubmed:articleTitle
Impact of admission glucose level and presence of diabetes mellitus on mortality in patients with non-ST-segment elevation acute coronary syndrome treated conservatively.
pubmed:affiliation
2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
pubmed:publicationType
Journal Article, Comparative Study, Multicenter Study